CANCER:

Medulloblastoma

Related cancers:

‹

›

No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	carmustine Sensitive: A1 - Approval FDA - 1 week (NewA1)	carmustine Sensitive: A1 - Approval FDA - 1 week - (New A1)
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline	cisplatin + cyclophosphamide + vincristine Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline	cisplatin + vincristine + lomustine Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	cyclophosphamide Sensitive: A2 - Guideline	cyclophosphamide Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	vismodegib Sensitive: A2 - Guideline	vismodegib Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	cisplatin + etoposide IV Sensitive: A2 - Guideline	cisplatin + etoposide IV Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	etoposide oral Sensitive: A2 - Guideline	etoposide oral Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	temozolomide Sensitive: A2 - Guideline	temozolomide Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline
No biomarker No biomarker	Medulloblastoma Medulloblastoma	No biomarker No biomarker	Medulloblastoma Medulloblastoma	CX-4945 Sensitive: B - Late Trials	CX-4945 Sensitive: B - Late Trials
PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	vismodegib Sensitive: C3 – Early Trials	vismodegib Sensitive: C3 – Early Trials
PTCH1 deletion PTCH1 deletion	Medulloblastoma Medulloblastoma	PTCH1 deletion PTCH1 deletion	Medulloblastoma Medulloblastoma	IPI 926 oral Sensitive: D – Preclinical	IPI 926 oral Sensitive: D – Preclinical
SUFU deletion SUFU deletion	Medulloblastoma Medulloblastoma	SUFU deletion SUFU deletion	Medulloblastoma Medulloblastoma	sonidegib Resistant: D – Preclinical	sonidegib Resistant: D – Preclinical
MYC expression MYC expression	Medulloblastoma Medulloblastoma	MYC expression MYC expression	Medulloblastoma Medulloblastoma	JHU395 Sensitive: D – Preclinical	JHU395 Sensitive: D – Preclinical
SMO D477G SMO D477G	Medulloblastoma Medulloblastoma	SMO D477G SMO D477G	Medulloblastoma Medulloblastoma	itraconazole Sensitive: D – Preclinical	itraconazole Sensitive: D – Preclinical
MYCN amplification MYCN amplification	Medulloblastoma Medulloblastoma	MYCN amplification MYCN amplification	Medulloblastoma Medulloblastoma	sonidegib Resistant: D – Preclinical	sonidegib Resistant: D – Preclinical
PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	sonidegib Sensitive: D – Preclinical	sonidegib Sensitive: D – Preclinical
SUFU mutation SUFU mutation	Medulloblastoma Medulloblastoma	SUFU mutation SUFU mutation	Medulloblastoma Medulloblastoma	SMO protein inhibitor Resistant: D – Preclinical	SMO protein inhibitor Resistant: D – Preclinical
PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	PTCH1 mutation PTCH1 mutation	Medulloblastoma Medulloblastoma	SMO protein inhibitor Sensitive: D – Preclinical	SMO protein inhibitor Sensitive: D – Preclinical
SMO D473H SMO D473H	Medulloblastoma Medulloblastoma	SMO D473H SMO D473H	Medulloblastoma Medulloblastoma	vismodegib Resistant: D – Preclinical	vismodegib Resistant: D – Preclinical
SMO D473H SMO D473H	Medulloblastoma Medulloblastoma	SMO D473H SMO D473H	Medulloblastoma Medulloblastoma	IPI 926 oral Sensitive: D – Preclinical	IPI 926 oral Sensitive: D – Preclinical
TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	CUDC-907 Sensitive: D – Preclinical	CUDC-907 Sensitive: D – Preclinical
TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	AN2025 + panobinostat Sensitive: D – Preclinical	AN2025 + panobinostat Sensitive: D – Preclinical
TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	panobinostat Sensitive: D – Preclinical	panobinostat Sensitive: D – Preclinical
TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	AN2025 Resistant: D – Preclinical	AN2025 Resistant: D – Preclinical
TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	TP53 mutation TP53 mutation	Medulloblastoma Medulloblastoma	AN2025 + sirolimus Sensitive: D – Preclinical	AN2025 + sirolimus Sensitive: D – Preclinical
MYC amplification MYC amplification	Medulloblastoma Medulloblastoma	MYC amplification MYC amplification	Medulloblastoma Medulloblastoma	PCM-075 Sensitive: D – Preclinical	PCM-075 Sensitive: D – Preclinical
MYCN amplification MYCN amplification	Medulloblastoma Medulloblastoma	MYCN amplification MYCN amplification	Medulloblastoma Medulloblastoma	olaparib + MK-8776 Sensitive: D – Preclinical	olaparib + MK-8776 Sensitive: D – Preclinical

Medulloblastoma

Associations(29)

Associations
(29)